Follow the Lir Life Sciences Corp. share price and the full directors' dealings record of the company, a listed issuer based in Canada. Shares are quoted on CA CA, under the supervision of SEDI. The latest transaction was disclosed on 8 June 2026 (56 - Grant of rights). Among the most active insiders: Nijjar, Harpreet. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
7 of 7 declarations
Lir Life Sciences Corp. is a company focused on developing innovative solutions in the life sciences sector. It is listed on the Toronto Stock Exchange under the symbol XTSE.